Jo-Ann’s Fabrics is offering free take-home-to-sew face mask kits. The PA store has kits of materials to sew 5 face masks (limit one kit per person at a time). Return the completed masks to the store.
Also, you can use elastic from other products, such as head bands, hair ties etc., which should be available at many stores.
Here’s a more complex mask that includes a pocket for filter material:
Background info & discussion on this mask
Impact of non-pharmaceutical interventions (NPIs)
to reduce COVID-19 mortality and healthcare demand
“Here we present the results of epidemiological modelling which has informed policy-making in the UK and other countries in recent weeks.” — March 16
Download the PDF Document
The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has informed policy-making in the UK and other countries in recent weeks. In the absence of a COVID-19 vaccine, we assess the potential role of a number of public health measures – so-called non-pharmaceutical interventions (NPIs) – aimed at reducing contact rates in the population and thereby reducing transmission of the virus. In the results presented here, we apply a previously published micro-simulation model to two countries: the UK (Great Britain specifically) and the US. We conclude that the effectiveness of any one intervention in isolation is likely to be limited, requiring multiple interventions to be combined to have a substantial impact on transmission.
Centers for Disease control and Prevention (CDC)
Letter from Dr. Robb at UC San Diego.
For those concerned about the coronavirus:
Subject: What I am doing for the upcoming COVID-19 (coronavirus) pandemic
by James Robb, MD UC San Diego
Dear Colleagues, as some of you may recall, when I was a professor of pathology at the University of California San Diego, I was one of the first molecular virologists in the world to work on coronaviruses (the 1970s). I was the first to demonstrate the number of genes the virus contained. Since then, I have kept up with the coronavirus field and its multiple clinical transfers into the human population (e.g., SARS, MERS), from different animal sources.
The current projections for its expansion in the U.S. are only probable, due to continued insufficient worldwide data, but it is most likely to be widespread in the US by mid to late March and April.
What to do, and not do